Kymera Therapeutics, Inc. (KYMR)
$106.68-4.82%Close
SELLBEAR · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8.8B
- Short % float
- 13.59%
- Days to cover
- 12.0
- SI change
- -5.9%
- 1W
- +0.66%
- 1M
- -6.94%
- vs SPY 1W
- +0.24%
- vs SPY 1M
- -9.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on KYMR?
- LOPJLB’s latest quantitative signal on Kymera Therapeutics, Inc. (KYMR) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is KYMR in?
- Kymera Therapeutics, Inc. (KYMR) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Kymera Therapeutics, Inc. (KYMR) do?
- Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which …